Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

KITE

KITE PHARMA, INC. (KITE)

Kite Pharma, Inc.
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:KITE
일자시간출처헤드라인심볼기업
2017/10/1406:05Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:KITEKite Pharma, Inc.
2017/10/0604:44Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KITEKite Pharma, Inc.
2017/10/0406:12Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KITEKite Pharma, Inc.
2017/10/0406:07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KITEKite Pharma, Inc.
2017/10/0406:02Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KITEKite Pharma, Inc.
2017/10/0405:57Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KITEKite Pharma, Inc.
2017/10/0405:56Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:KITEKite Pharma, Inc.
2017/10/0405:44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KITEKite Pharma, Inc.
2017/10/0322:03Edgar (US Regulatory)(25-NSE)NASDAQ:KITEKite Pharma, Inc.
2017/10/0321:46Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
2017/10/0321:45Business WireGilead Sciences Completes Acquisition of Kite Pharma, Inc.NASDAQ:KITEKite Pharma, Inc.
2017/10/0321:17Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
2017/10/0321:00Business WireGilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc.NASDAQ:KITEKite Pharma, Inc.
2017/09/2621:54Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
2017/09/2621:40Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
2017/09/2621:30Business WireGilead Sciences and Kite Pharma Announce Expiration of Hart-Scott-Rodino Waiting PeriodNASDAQ:KITEKite Pharma, Inc.
2017/09/2606:17Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
2017/09/2606:13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KITEKite Pharma, Inc.
2017/09/2605:31Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
2017/09/2305:18Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
2017/09/1906:29Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
2017/09/1605:52Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
2017/09/0906:30Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:KITEKite Pharma, Inc.
2017/09/0906:24Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
2017/09/0902:37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KITEKite Pharma, Inc.
2017/09/0805:12Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:KITEKite Pharma, Inc.
2017/09/0605:13Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:KITEKite Pharma, Inc.
2017/09/0605:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KITEKite Pharma, Inc.
2017/09/0601:24Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:KITEKite Pharma, Inc.
2017/09/0206:28Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:KITEKite Pharma, Inc.
 검색 관련기사 보기:NASDAQ:KITE